Clinical Research Directory
Browse clinical research sites, groups, and studies.
Mitochondrial Function After Ketamine
Sponsor: Sheba Medical Center
Summary
The goal of this observational study is to learn about the role of mitochondria in response to S-ketamine. in individuals with Treatment-Resistant Depression. the Research Questions are 1. Does S-ketamine treatment modulate mitochondrial function in peripheral blood cells, as reflected by mitochondrial content and circulating mitochondrial biomarkers such as GDF15? 2. Can changes in mitochondrial function serve as biomarkers for predicting or monitoring clinical response to S-ketamine treatment? Samples will be collected at baseline, 3 hours after the first treatment, and 6 weeks post-exposure, and compared between responders and non-responders
Official title: Assessment of Mitochondrial Parameters in Blood Before and After S-Ketamine Treatment
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
30
Start Date
2026-02
Completion Date
2028-01
Last Updated
2026-02-10
Healthy Volunteers
Yes
Conditions
Interventions
S (+) Ketamine
the patients are treated with S-Ketamine in order to treat there Treatment-Resistant Depression via inhalation
Locations (1)
Sheba Medical Center
Ramat Gan, Israel, Israel